Cross-talks between circadian timing system and cell division cycle determine cancer biology and therapeutics

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 72, Issue , 2007, Pages 465-475

  Levi F ^a,b   Filipski, E ^a,b   Iurisci, I ^a,b   Li, X M ^a,b   Innominato, P ^a,b  

^a HÔPITAL PAUL BROUSSE   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; BIOLOGICAL MODEL; CELL DIVISION; CHRONOTHERAPY; CIRCADIAN RHYTHM; FEMALE; GENETICS; HUMAN; JET LAG; MALE; NEOPLASM; PATHOLOGY; PATHOPHYSIOLOGY; PHOTOPERIODICITY; PHYSIOLOGY; REVIEW; SUPRACHIASMATIC NUCLEUS; CANCER PATIENT; CANCER SURVIVAL; CANCER THERAPY; CELL PROLIFERATION; DOWN REGULATION; DRUG DELIVERY SYSTEM; GENE EXPRESSION; MALIGNANT NEOPLASM; MATHEMATICAL MODEL; MOLECULAR CLOCK; NONHUMAN; QUALITY OF LIFE; SYSTEMS BIOLOGY; THERAPEUTIC INDEX; TUMOR GROWTH;

ANIMALS; CELL DIVISION; CHRONOTHERAPY; CIRCADIAN RHYTHM; FEMALE; HUMANS; JET LAG SYNDROME; MALE; MODELS, BIOLOGICAL; NEOPLASMS; PHOTOPERIOD; SUPRACHIASMATIC NUCLEUS;

ANTIINFECTIVE AGENT;

EID: 48249093003     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.2007.72.030     Document Type: Conference Paper

References (88)

1. Aggarwal B.B., Shishodia S., Sandur S.K. Pandey M.K., and Sethi G. 2006. Inflammation and cancer: How hot is the link? Biochem. Pharmacol. 72: 1605.
2. Altinok A., Lévi F., and Goldbeter A. 2007. A cell cycle automaton model for probing circadian patterns of anticancer drug delivery. Adv. Drug Delivery Rev. 59: 1036.
3. Balsalobre A. 2000. Multiple signaling pathways elicit circadian gene expression in cultured Rat-1 fibroblasts. Curr. Biol. 10: 1291.
4. Balsalobre A., Damiola F., and Schibler U. 1998. A serum shock induces circadian gene expression in mammalian tissue culture cells. Cell 93: 929.
5. Balsalobre A., Brown S.A., Marcacci L., Tronche F., Kellendonk C., Reichardt H.M., Schutz G., and Schibler U. 2000. Resetting of circadian time in peripheral tissues by glucocorticoid signaling. Science 289: 2344.
6. Bartek J. and Lukas J. 2007. DNA damage checkpoints: From initiation to recovery or adaptation. Curr. Opin. Cell Biol. 19: 238.
7. Bensaad K. and Vousden K.H. 2007. P53: New roles in metabolism. Trends Cell Biol. 17: 286.
8. Bjarnason G. and Jordan R. 2002. Rhythms in human gastrointestinal mucosa and skin. Chronobiol. Int. 19: 129.
9. Bjarnason G., Seth A., Wang Z., Blanas N., Straume M., and Martino T. 2007. Diurnal rhythms in gene expression in human oral mucosa: Implications for gender differences in toxicity, response and survival and optimal timing of targeted therapy. 2007. In Proceedings of the 43rd Annual Meeting ASCO 25: 98s. (Abstr. 2507.)
10. Bjarnason G., Jordan R., Wood P., Li Q., Lincoln D., Sothern R., Hrushesky W., and Ben-David Y. 2001. Circadian expression of clock genes in human oral mucosa and skin: Association with specific cell-cycle phases. Am. J. Pathol. 58: 1793.
11. Bourin P., Ledain A., Beau J., Mille D., and Levi F. 2002. Invitro circadian rhythm of murine bone marrow progenitor production. Chronobiol. Int. 19: 57.
12. Brown S., Zumbrunn G., Fleury-Olela F., Preitner N., and Schibler U. 2002. Rhythms of mammalian body temperature can sustain peripheral circadian clocks. Curr. Biol. 12: 1574.
13. Burns E.R., Scheving L.E., Pauly J.E., and Tsai T. 1976. Effect of altered lighting regimens, time-limited feeding, and presence of Ehrlich ascites carcinoma on the circadian rhythm in DNA synthesis of mouse spleen. Cancer Res. 36: 1538.
14. Cavadini G., Petrzilka S., Kohler P., Jud C., Tobler I., Birchler T., and Fontana A. 2007. TNF-α suppresses the expression f clock genes by interfering with E-box-mediated transcription. Proc. Natl. Acad. Sci. 104: 12843.
15. Chen S.T., Choo K.B., Hou M.F., Yeh K.T., Kuo S.J.. and Chang J.G. 2005. Deregulated expression of the PER1; PER2 and PER3 genes in breast cancers. Carcinogenesis 26: 1241.
16. Chen Z., Odstrcil E.A., Tu B.P., and McKnight S.L. 2007. Restriction of DNA replication to the reductive phase of the metabolic cycle protects genome integrity. Science 316: 1916.
17. Cheng M.Y., Bullock C.M., Li C., Lee A.G., Bermak J.C., Belluzzi J., Weaver D.R., Leslie F.M., and Zhou Q.Y. 2002. Prokineticin 2 transmits the behavioural circadian rhythm of the suprachiasmatic nucleus. Nature 417: 405.
18. Chilov D., Hofer T., Bauer C., Wenger R.H., and Gassmann M. 2001. Hypoxia affects expression of circadian genes PER1 and CLOCK in mouse brain. FASEB J. 15: 2613.
19. Clairambault J. 2007. Modelling oxaliplatin drug delivery to circadian rhythms in drug metabolism and host tolerance. Adv. Drug Delivery Rev. (in press).
20. Davidson A.J., Straume M., Block G.D., and Menaker M. 2006. Daily timed meals dissociate circadian rhythms in hepatoma and healthy host liver. Int. J. Cancer 118: 1623.
21. Delaunay F. and Laudet V. 2002. Circadian clock and microarrays: Mammalian genome gets rhythm. Trends Genet. 18: 595.
22. De Vita V., Hellman S., and Rosenberg S., Eds. 2007. Cancer: Principles and practice of oncology, 7th edition. Lippincott, Philadelphia, Pennsylvania.
23. Dickmeis T., Lahiri K., Nica G., Vallone D., Santoriello C., Neumann C.J., Hammerschmidt M., and Foulkes N.S. 2007. Glucocorticoids play a key role in circadian cell cycle rhythms. PLOS Biol. 5: 179.
24. Fan Y., Hida A., Anderson D.A., Izumo M., and Johnson C.H. 2007. Cycling of CHRYPTOCHROME proteins is not necessary for circadian-clock function in mammalian fibroblasts. Curr. Biol. 17: 1091.
25. Filipski E., Innominato P.F., Wu M.W., Li X.M., Iacobelli S., Xian L.J., and Lévi F. 2005. Effects of light and food schedules on liver and tumor molecular clocks. J. Natl. Cancer Inst. 97: 507.
26. Filipski E., Delaunay F., King V.M., Wu M.W., Claustrat B., Gréchez-Cassiau A., Guettier C., Hastings M.H., and Lévi F. 2004a. Effects of chronic jet lag on malignant growth in mice. Cancer Res. 64: 7879.
27. Filipski E., King V.M., Etienne M.C., Li X.M., Claustrat B., Granda T.G., Milano G., Hastings M.H., and Lévi F. 2004b. Persistent twenty-four hour changes in liver and bone marrow despite suprachiasmatic nuclei ablation in mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287: R844.
28. Filipski E., King V.M., Li X.M., Granda T., Mormont M.C., Liu X.H., Claustrat B., Hastings M., and Lévi F. 2002. Host circadian clock as a control point in tumor progression. J. Natl. Cancer Inst. 94: 690.
29. Fu L. and Lee C.C. 2003. The circadian clock: pacemaker and tumour suppressor. Nat. Rev Cancer 3: 350.
30. Fu L., Pelicano H., Liu J., Huang P., and Lee C.C. 2002. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 111: 41.
31. Gauger M.A. and Sancar A. 2005. Cryptochrome, circadian cycle, cell cycle checkpoints, and cancer. Cancer Res. 65: 6828.
32. Gery S., Virk R.K., Chumakov K., Yu A., and Koeffler H.P. 2007a. The clock gene Per2 links the circadian system to the estrogen receptor. Oncogene (in press).
33. Gery S., Gombart A.F., Yi W.S., Koeffler C., Hofmann W.K., and Koeffler H.P. 2005. Transcription profiling of C/EBP targets identifies Per2 as a gene implicated in myeloid leukemia. Blood 106: 2827.
34. Gery S., Komatsu N., Baldjyan L., Yu A., Koo D., and Koeffler H.P. 2006. The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells. Mol. Cell 22: 375.
35. Gery S., Komatsu N., Kawamata N., Miller C.W., Desmond J., Virk R.K., Marchevsky A., Mckenna R., Taguchi H., and Koeffler H.P. 2007b. Epigenetic silencing of the candidate tumor suppressor gene Per1 in non-small cell lung cancer. Clin. Cancer Res. 13: 1399.
36. Giacchetti S., Bjarnason G., Garufi C., Genet D., Iacobelli S., Tampellini M., Smaaland R., Focan C., Coudert B., Humblet Y., Canon J.L., Adenis A., Lo Re G., Carvalho C., Schueller J., Anciaux N., Lentz M.A., Baron B., Gorlia T., and Lévi F. (European Organisation for Research and Treatment of Cancer Chronotherapy Group). 2006. Phase III trial of 4-day chronomodulated vs 2-day conventional delivery of 5-fluorouracil, leucovorin and oxaliplatin as first line chemotherapy of metastatic colorectal cancer: The EORTC. J. Clin. Oncol. 24: 3562.
37. Golstein P. and Kroemer G. 2006. Cell death by necrosis: Towards a molecular definition. Trends Biochem. Sci. 32: 37.
38. Granda T.G., Liu X.H., Smaaland R., Cermakian N., Filipski E., Sassone-Corsi P., and Lévi F. 2005. Circadian regulation of cell cycle and apoptosis proteins in mouse bone marrow and tumour. FASEB J. 19: 304.
39. Hanahan D. and Weinberg R.A. 2000. The hallmarks of cancer: A review. Cell 100: 57.
40. Hastings M., Reddy A.B., and Maywood E.S. 2003. A clockwork web: Circadian timing in brain and periphery in health and disease. Nat. Rev. Neurosci. 4: 649.
41. Hua H., Wang Y., Wan C., Liu Y., Zhu B., Wang X., Wang Z., and Ding J.M. 2007. Inhibition of tumorigenesis by intratumoral delivery of the circadian gene mPer2 in C57BL/6 mice. Cancer Gene Ther. 14: 815.
42. Hua H., Wang Y., Wan C., Liu Y., Zhu B., Yang C., Wang X., Wang Z., Cornelissen-Guillaume G., and Halberg F. 2006. Circadian gene mPer2 overexpression induces cancer cell apoptosis. Cancer Sci. 97: 589.
43. Hunt T. and Sassone-Corsi P. 2007. Riding tandem: Circadian clocks and the cell cycle. Cell 129: 461.
44. Iurisci I., Filipski E., Reinhardt J., Bach S., Gianella-Borradori A., Iacobelli S., Meijer L., and Lévi F. 2006. Improved tumor control through circadian clock induction by seliciclib, a cyclin-dependent kinase inhibitor. Cancer Res. 66: 10720.
45. Kalsbeek A., Palm I.F., La Fleur S.E., Scheer F.A., Perreau-Lenz S., Ruiter M., Kreier F., Cailotto C., and Buijs R.M. 2006. SCN outputs and the hypothalamic balance of life. J. Biol. Rhythms 21: 458.
46. Keith B. and Simon C. 2007. Hypoxia-inducible factors, stem cells and cancer. Cell 129: 465.
47. Knoepfler P.S. 2007. Myc goes global: New tricks for an old oncogene. Cancer Res. 67: 5061.
48. Kornmann B., Schaad O., Bujard H., Takahashi J.S., and Schibler U. 2007. System-driven and oscillator-dependent circadian transcription in mice with a conditionnlly active liver clock. PLoS Biol. 5: 179.
49. Koyanagi S., Kuramoto Y., Nakagawa H., Aramaki H., Ohdo S., Soeda S., and Shimeno H.A. 2003. Molecular mechanism regulating circadian expression of vascular endothelial growth factor in tumor cells. Cancer Res. 63: 7277.
50. Kramer A., Yang F.C., Snodgrass P., Li X., Scammell T.E., Davis F.C., and Weitz C.J. 2001. Regulation of daily locomotor activity and sleep by hypothalamic EGF receptor signaling. Science 294: 2511.
51. Kraves S. and Weitz C.J. 2006. A role for cardiotrophin-like cytokine in the circadian control of mammalian locomotor activity. Nat. Neurosci. 9: 212.
52. Krugluger W., Brandstaetter A., Kallay E., Schueller J., Krexner E., Kriwanek S., Bonner E., and Cross H.S. 2007. Regulation of genes of the circadian clock in human colon cancer: Reduced Period-1 and dihydropyrimidine dehydrogenase transcription correlates in high-grade tumors. Cancer Res. 67: 7917.
53. Lakatua D.J., White M., Sackett-Lundeen L.L., and Haus E. 1983. Change in phase relations of circadian rhythms in cell proliferation induced by time-limited feeding in BALB/c X DBA/2F1 mice bearing a transplantable Harding-Passey tumor. Cancer Res. 43: 4068.
54. Lévi F. 2001. Circadian chronotherapy for human cancers. Lancet Oncol. 2: 307.
55. Lévi F. and Schibler U. 2007. Circadian rhythms: Mechanisms and therapeutic implications. Annu. Rev. Pharmacol. Toxicol. 47: 593.
56. Lévi F., Zidani R., and Misset J.L. (International Organization for Cancer Chronotherapy). 1997. Randomized multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. Lancet 350: 681.
57. Lévi F., Focan C., Karaboué A., de la Valette V., Focan-Henrard D., Baron B., Kreutz M., and Giacchetti S. 2007. Implications of circadian clocks for the rhythmic delivery of cancer therapeutics. Adv Drug Delivery Rev. 59: 1015.
58. Liu G. and Chen X. 2006. Regulation of the p53 transcriptional activity. J. Cell. Biochem. 97: 448.
59. Matsuo T., Yamaguchi S., Mitsui S., Emi A., Shimoda F., and Okamura H. 2003. Control mechanism of the circadian clock for timing of cell division in vivo. Science 302: 255.
60. Mormont M.C. and Lévi F. 2003. Cancer chronotherapy: Principles, applications, and perspectives. Cancer 97: 155.
61. Mormont M.C., Waterhouse J., Bleuzen P., Giacchetti S., Jami A., Bogdan A., Lellouch J., Misset J.L., Touitou Y., and Lévi F. 2000. Marked 24-h rest-activity rhythms are associated with better quality of life, better response and longer survival in patients with metastatic colorectal cancer and good performance status. Clin. Cancer Res. 6: 3038.
62. Motzkus D., Albrecht U., and Maronde E. 2002. The human Per 1 gene is inducible by interleukin-6. J. Mol. Neurosci. 18: 105.
63. Nagashima K., Matsue K., Konishi M., Iidaka C., Miyazaki K., Ishida N., and Kanosue K. 2005. The involvement of Cry1 and Cry2 genes in the regulation of the circadian body temperature rhythm in mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288: R329.
64. Nagoshi E., Saini C., Bauer C., Laroche T., Naef F., and Schibler U. 2004. Circadian gene expression in individual fibroblasts: Cell-autonomous and self-sustained oscillators pass time to daughter cells. Cell 119: 693.
65. Perpoint B., Le Bousse-Kerdiles C., Clay D., Smadja-Joffe F., Deprés-Brummer P., Laporte-Simitsidis S., Jasmin C., and Lévi F. 1995. In vitro chronopharmacology of recombinant mouse IL-3, mouse GM-CSF and human G-CSF on murine myeloid progenitor cells. Exp. Hematol. 23: 362.
66. Rajput A., Koterba A.P., Kreisberg J.I., Foster J.M., Willson J.K.V., and Brattain M.G. 2007. A novel mechanism of resistance to epidermal growth factor receptor antagonism in vivo. Cancer Res. 67: 665.
67. Rich T. 2007. Symptom clusters in cancer patients and their relation to EGFR ligand modulation of the circadian axis. J. Support. Oncol. 5: 167.
68. Rich T., Innominato P.F., Boerner J., Mormont M.C., Iacobelli S., Baron B., Jasmin C., and Lévi F. 2005. Elevated serum cytokines correlated with altered behaviour, serum cortisol rhythm, and dampened 24 hour rest-activity patterns in patients with metastatic colorectal cancer. Clin. Cancer Res. 11: 1757.
69. Sanchez I. and Dynlacht B.D. 2005. New insights into cyclins, CDKs, and cell cycle control: A review. Semin. Cell Dev. Biol. 16: 311.
70. Santamaría D., Barrière C., Cerqueira A., Hunt S., Tardy C., Newton K., Cáceres J.F., Dubus P., Malumbres M., and Barbacid M. 2007. Cdk1 is sufficient to drive the mammalian cell cycle. Nature 448: 811.
71. Scheving L.E. 1959. Mitotic activity in human epidermis. Anat. Rec. 135: 7.
72. Scheving L.E., Tsai T.-H., Scheving L.A., Feuers R.J., and Kanabrocki E.L. 1992. Normal and abnormal cell proliferation in mice as it related to cancer. In Biological rhythms in clinical and laboratory medicine (ed. Y. Touitou and E. Haus), p. 566. Springer-Verlag, Berlin.
73. 3H]-thymidine incorporation into deoxyribonucleic acid in mouse intestinal tract, mitotic index of corneal epithelium, and serum corticosterone. Anat. Rec. 205: 239.
74. Sclafani R.A. and Holzen T.M. 2007. Cell cycle regulation of DNA replication. Annu. Rev. Genet. (in press).
75. Sephton S.E., Sapolsky R.M., Kraemer H.C., and Spiegel D. 2000. Diurnal cortisol rhythm as a predictor of breast cancer survival. J. Natl. Cancer Inst. 92: 994.
76. Shih M.C., Yeh K.T., Tang R.P., Chen J.C. and Chang J.G. 2006. Promoter methylation in circadian genes of endometrial cancers detected by methylation specific PCR. Mol. Carcinog. 45: 732.
77. Shiloh Y. 2003. ATM and related protein kinases: Safeguarding genome integrity. Nat. Rev. Cancer 3: 155.
78. Smaaland R., Sothern R.B., Laerum O.D., and Abrahamsen J.F. 2002. Rhythms in human bone marrow and blood cells. Chronobiol. Int. 19: 101.
79. Smaaland R., Laerum O.D., Lote K., Sletvold O., Sothern R.B., and Bjerknes R. 1991. DNA synthesis in human bonne marrow is circadian stage dependent. Blood 77: 2603.
80. Touitou Y., Lévi F., Bogdan A., Benavides M., Bailleul F., and Misset J.L. 1995. Rhythm alteration in patients with metastatic breast cancer and poor prognostic factors. J. Cancer Res. Clin. Oncol. 121: 181.
81. Tsinkalovsky O., Filipski E., Rosenlund B., Sothern R.B., Eiken H.G., Wu M.W., Claustrat B., Bayer J., Lévi F., and Laerum O.D. 2006. Circadian expression of clock genes in purified hematopoietic stem cells is developmentally regulated in mouse bone marrow. Exp. Hematol. 34: 1248.
82. Tu B. and McKnight S.L. 2006. Metabolic cycles as an underlying basis of biological oscillations. Nat. Rev. Mol. Cell Biol. 7: 696.
83. Unsal-Kaçmaz K., Mullen T.E., Kaufmann W.K., and Sancar A. 2005. Coupling of human circadian and cell cycles by the timeless protein. Mol. Cell. Biol. 25: 3109.
84. Vogelstein B., Lane D., and Levine A.J. 2000. Surfing the p53 network. Nature 408: 307.
85. Wu M.W., Li X.M., Xian L.J., and Lévi F. 2004. Effects of meal timing on tumor progression in mice. Life Sci. 75: 1181.
86. Xu Y., Padiath Q.S., Shapiro R.E., Jones C.R., Wu S.C., Saigoh N., Saigoh K., Ptáček L.J., and Fu Y.H. 2005. Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome. Nature 434: 640.
87. Yeh K.T., Yang M.Y., Liu T.C., Chen J.C., Chan W.L., Lin S.F., and Chang J.G. 2005. Abnormal expression of period 1 (PER1) in endometrial carcinoma. J. Pathol. 206: 111.
88. You S., Wood P.A., Xiong Y., Kobayashi M., Du-Quiton J., and Hrushesky W.J.M. 2005. Daily coordination of cancer growth and circadian clock gene expression. Breast Cancer Res. Treat. 91: 47.